A Janus polydopamine nanomotor hydrogel enables enhanced tumor penetration and potent synergistic photothermal-photodynamic therapy Authors: Jiahui Jiang, Yangbo Lv, Mengyuan Ma, Hanyue Xu, Mingxin Sun, Cheng Chen, Tao Cao, Yue Zhang, Peng Cao, Qichen Zhan, Jianguang Xu Published: 2026 ABSTRACT Hydrogels are widely recognized as promising carriers for antitumor drug delivery owing to their tunable physicochemical properties. However, elevated interstitial fluid pressure and a dense extracellular matrix within tumors often restrict efficient drug penetration. Herein, we developed a nanomotor-based injectable hydrogel (CPPZ@R837) that integrates Janus-type polydopamine nanobowls (PDA NBs) functionalized with platinum nanoparticles (Pt NPs) as catalytic propellants and zinc phthalocyanine (ZnPc) as a photosensitizer to construct PPZ nanomotors (NMs). These PPZ NMs, together with the immunoadjuvant imiquimod (R837), were embedded into a chitosan (CTS)-based thermosensitive hydrogel through Michael addition and Schiff base reactions. Upon laser irradiation, the hydrogel underwent a sol-gel phase transition, enabling the controlled release of PPZ NMs and R837. The Pt NPs catalyzed the decomposition of tumor-overexpressed hydrogen peroxide (H2O2) to generate oxygen (O2), which not only provided propulsion for the NMs but also alleviated tumor hypoxia, thereby enhancing the efficacy of photodynamic therapy (PDT). This multifunctional system markedly improved intratumoral drug penetration and exhibited potent antitumor performance, achieving significant tumor growth inhibition (83.7%) and effective suppression of metastasis. Collectively, these findings highlight the great potential of this nanomotor-based hydrogel as an advanced platform for synergistic cancer therapy. Introduction Cancer therapy remains one of the major global challenges in modern medicine. Although conventional approaches such as surgical resection, radiotherapy, and chemotherapy are widely applied in clinical practice, their inherent limitations have become increasingly evident. Surgical resection is frequently accompanied by high risks of recurrence and metastasis; radiotherapy shows limited efficacy against deeply seated tumors; and chemotherapeutic agents often lack specificity, leading to systemic toxicity [1,2]. Moreover, solid tumors exhibit intrinsic resistance to chemotherapeutic drugs and radiotherapy due to their unique biological and structural features, rendering treatment outcomes unsatisfactory. These clinical obstacles underscore the pressing need to develop next-generation drug delivery strategies that can achieve precise tumor targeting, deep tissue penetration, and efficient therapeutic efficacy [3,4] (see Scheme 1)Scheme 1Schematic illustration of the preparation of the CPPZ@R837 hydrogel and its application for cancer therapy. Schematic illustration of the preparation of the CPPZ@R837 hydrogel and its application for cancer therapy. In the pursuit of localized and sustained cancer therapy, hydrogels have emerged as one of the most versatile drug delivery platforms. Hydrogels are three-dimensional polymer networks capable of absorbing large amounts of water, thereby mimicking extracellular matrix-like environments [[5], [6], [7]]. Their intrinsic properties-including high biocompatibility, adjustable mechanical strength, and facile encapsulation of diverse therapeutic agents-make them particularly attractive for tumor drug delivery. Injectable hydrogels, in particular, offer significant clinical advantages: they can be delivered minimally invasively, conform to irregular tumor geometries, and provide controlled release of chemotherapeutic drugs, immunomodulators, or photosensitizers at the tumor site. Such features have positioned hydrogels as a promising alternative to conventional systemic administration. However, despite these merits, hydrogel-based formulations face critical limitations in solid tumor therapy. Once injected peritumorally, most hydrogels act as passive depots, relying predominantly on diffusion to release drugs into surrounding tissues [8]. This mode of delivery is severely constrained by the hostile tumor microenvironment. Elevated interstitial fluid pressure, irregular vasculature, and a dense extracellular matrix form formidable biophysical barriers that impede drug distribution [[9], [10], [11]]. As a result, therapeutic molecules tend to remain localized near the periphery of tumors, leaving hypoxic and poorly perfused regions untreated. Such incomplete drug penetration not only compromises treatment efficacy but also contributes to the survival of invasive tumor cells that promote recurrence and distant metastasis [12]. Overcoming these microenvironmental barriers represents a central challenge for advancing hydrogel-based drug delivery systems from concept to clinical translation. Recent years have witnessed the emergence of nanomotors (NMs), which provide a paradigm-shifting solution to the limitations of passive drug diffusion [13]. NMs are nanoscale devices capable of autonomous or externally guided motion, propelled by catalytic reactions, ultrasound, magnetic fields, or light irradiation. Unlike static nanoparticles, NMs exhibit active propulsion that enables them to navigate complex biological environments, penetrate deeper into tissues, and achieve more homogeneous intratumoral distribution [[14], [15], [16]]. Importantly, catalytic NMs that utilize tumor-associated substrates, such as hydrogen peroxide, not only provide thrust for motion but also remodel the TME by alleviating hypoxia, a major factor underlying resistance to radiotherapy and photodynamic therapy (PDT) [[17], [18], [19]]. Despite these transformative advantages, the integration of NMs with biocompatible hydrogel matrices remains in its infancy. Existing studies have largely focused on NMs as standalone agents, whereas the synergistic combination of NMs propulsion with hydrogel-based controlled release has rarely been explored. Herein, we reported an innovative nanomotor-integrated composite hydrogel that combined the spatiotemporal control of injectable hydrogels with the active penetration capability of catalytic NMs. In cancer therapy, residual microlesions are highly susceptible to inducing recurrence and distant metastasis. Although conventional hydrogel-based drug delivery systems can achieve localized sustained release of antitumor agents and mitigate systemic toxic side effects, they fail to effectively modulate the immunosuppressive milieu of the tumor microenvironment and are thus unable to elicit a long-term antitumor immune response required for the eradication of residual tumor cells and circulating tumor cells. To address this critical challenge and enhance both the antitumor efficacy and long-term prognosis of hydrogel-based drugs, we incorporated immunoadjuvant imiquimod (R837) into the hydrogel system. As a selective Toll-like receptor 7 (TLR7) agonist, R837 directly acts on antigen-presenting cells such as dendritic cells, promoting their maturation and inducing the production of T helper 1 (Th1)-type cytokines. This process initiates a specific cytotoxic T lymphocyte response, enabling the precise recognition and elimination of residual tumor cells, as well as the establishment of long-term immune memory [20,21]. In brief, this system was constructed using Janus-type polydopamine nanobowls (PDA NBs) as the core, decorated with platinum (Pt) NPs as catalytic propellants and zinc phthalocyanine (ZnPc) as a photosensitizer, thereby generating multifunctional PPZ NMs. The NMs and R837 were subsequently incorporated into a chitosan (CTS)-based thermosensitive hydrogel via Michael addition and Schiff base reactions, resulting in an injectable composite hydrogel (CPPZ@R837 hydrogel). Upon near-infrared laser irradiation, the photothermal effect of PDA NBs induced phase transition of the hydrogel, enabling controlled, on-demand release of NMs. Once liberated, Pt NPs catalyzed the decomposition of endogenous hydrogen peroxide (H2O2) to generate O2, which simultaneously fueled NMs propulsion for deeper tumor penetration and mitigated tumor hypoxia to amplify PDT efficacy. By integrating three synergistic functions-on-demand release, autonomous propulsion, and tumor microenvironment regulated the CPPZ@R837 hydrogel system directly addressed two long-standing barriers in solid tumor therapy: limited drug penetration and hypoxia-induced resistance. Our results demonstrated that this multifunctional platform not only achieved profound tumor growth inhibition but also effectively suppressed metastasis, highlighting its translational potential as a next-generation intelligent hydrogel system. More broadly, this study established a conceptual framework for transforming hydrogels from passive reservoirs into active, self-propelled therapeutic depots, thereby opening new avenues for precision oncology. Experimental section Reagents and apparatus H2O2 (30%), dimethyl sulfoxide (DMSO) and anhydrous ethanol were purchased from Sinopharm Chemical Reagent Co., Ltd. Dopamine hydrochloride (DA HCl), Tris, Hexachloroplatinic acid hexahydrate, Acetic acid and 9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABDA) were purchased from Shanghai Aladdin Industrial Co., Ltd. Fetal Bovine Serum (FBS) were purchased from Sigma-Aldrich. Chitosan (CTS), [Ru (dpp)3]Cl2 and sodium cyanoborohydride were purchased from Shanghai Bide Pharmatech Co., Ltd. 2′,7′-Dichlorodihydrofluorescein diacetate (DCFH-DA) and DAPI dihydrochloride were purchased from Beyotime Biotechnology. Cell Counting Kit-8 (CCK8) was purchased from Shanghai Adamas Reagent Co., Ltd. Penicillin-Streptomycin and Dulbecco's Modified Eagle Medium (DMEM) were purchased from Gibco. Calcein-AM/PI was purchased from Yeasen Biotechnology (Shanghai) Co., Ltd. The UV absorption spectra of different samples were measured using a UV spectrophotometer (Cary 60, Agilent, USA). The fluorescence emission capabilities of various drugs were evaluated using fluorescence spectroscopy (F-4700, Hitachi, Japan). The particle size distribution and surface zeta potential of samples were detected using a dynamic light scattering analyzer (Zetasizer pro, Malvern Panalytical, UK). The three-dimensional network architectures of various hydrogels were examined using cryogenic scanning electron microscopy (Cryo-SEM, SU3500, Hitachi, Japan). The deformation and flow characteristics of composite hydrogels were investigated using a rotational rheometer (MCR302, Anton Paar, Austria). The microscopic morphology of nanoparticles was characterized by transmission electron microscopy (TEM, JEM-2100 F, JEOL, Japan). The zinc content in nanomotors was quantified using inductively coupled plasma optical emission spectrometry (ICP-OES, ICAP RQ, Thermo Fisher Scientific, USA). The motion trajectories of nanomotors were analyzed using nanoparticle tracking analysis (NTA, Nano Sight NS300, Malvern Panalytical, UK). Cell viability before and after drug treatment was assessed using fluorescence microscopy (IX73, Olympus, Japan). The metabolic behavior of fluorescently labeled drugs was monitored in tumor-bearing mice using a small animal imaging system (X5 SE, Tanon, USA). Preparation of PPZ NMs Synthesis of PDA NBs Tris (30 mg) was dissolved in 50 mL of deionized water, followed by the addition of 6.25 mL of 1-propanol under continuous stirring for 2 min. Subsequently, DA·HCl (50 mg) was introduced into the solution, and the mixture was stirred at room temperature (450 rpm) for 1 h. The resulting product was collected by high-speed centrifugation (12000 rpm, 5 min) and washed three times with ethanol to remove unreacted residues. Finally, the purified product was redispersed in deionized water at a concentration of 1.0 mg mL−1 and designated as PDA NBs. The suspension was stored at 4 °C for subsequent use. Synthesis of ultra-small Pt NPs The chloroplatinic acid solution (0.1 M) was prepared by dissolving H2PtCl6·6H2O (100 mg) in 2 mL of deionized water. In parallel, a reducing agent solution was obtained by dissolving NaBH3CN (30 mg) in deionized water, followed by the gradual addition of 1 mL of the 0.1 M chloroplatinic acid solution. The reaction mixture was then stirred under dark conditions at room temperature (450 rpm) for 2 h. The resulting Pt NPs was collected and stored at 4 °C until further use. Fabrication of PPZ NMs The colloidal suspension of PDA@Pt NBs (PP NBs) was synthesized by mixing PDA NBs (1 mg mL−1, 2 mL) with the pre-synthesized Pt NPs (0.4 mL) in 8 mL of deionized water under continuous stirring (450 rpm, 12 h). The product was isolated via centrifugation (11000 rpm, 5 min), washed by water for three times, and finally redispersed in 2 mL of water to yield PP NBs (1 mg mL−1, PDA NBs basis). Inductively coupled plasma mass spectrometry (ICP-MS) was employed to evaluate the Pt NPs loading capacity, with triplicate samples conducted for statistical validation. ZnPc was synthesized according to the previously reported procedure of our research group [22]. PPZ NMs were prepared by incubating PP NBs (1 mg mL−1, 2 mL) with ZnPc (5 mM, 0.2 mL) in 8 mL of deionized water under continuous stirring against light (450 rpm, 6 h). The crude PPZ NMs were collected by centrifugation (11000 rpm, 5 min), purified by deionized water for three times, and standardized to 1 mg mL−1 (PDA NBs basis). The ZnPc loading efficiency was indirectly quantified by monitoring the decrease in 680 nm absorbance of the supernatant between initial (0 h) and final (6 h) timepoints. Triplicate samples ensured statistical validation. Preparation of the CPPZ@R837 hydrogel A precursor solution was formulated by combining acetic acid (1 M, 90 μL), PPZ NMs (1 mg mL−1, 0.6 mL), and R837 (20 mg mL−1, 18 μL). The volume was adjusted to 1.2 mL with deionized water (472 μL), and the mixture was homogenized. Subsequently, chitosan (52.5 mg) was introduced and dissolved via vigorous stirring. After standing for 5 min at room temperature, the composite hydrogel was obtained, with a final PDA NBs concentration of 0.5 mg mL−1. Evaluation of photothermal conversion efficiency The photothermal conversion efficiency of PPZ NMs was evaluated using a 0.05 mg mL−1 aqueous suspension. Under laser irradiation, real-time temperature kinetics were tracked until stabilization. The subsequent cooling phase was analyzed to determine the energy conversion efficiency. The photothermal conversion efficiency was calculated using the following formulas [23,24].(1)η=hs(Tmax−Tsurr)−QsI(1−10−A808)×100%(2)θ=T−TSurrTmax−TSurr(3)t=−τslnθ(4)hs=mDCDτsThe maximum steady-state temperature (Tmax) was 54.9 °C; the ambient temperature (Tsurr) was 19.8 °C; the laser power intensity (I) was 0.93 W cm−2; the absorbance of PPZ NMs at 808 nm (A808), which was 0.35; the mass of water (mD) was 0.5 g; the specific heat capacity of water (cD) was 4.2 J/(g·°C). The heat loss from the system (Qs) was calculated to be 2.69 mW. The overall heat transfer parameter hs (where h is the heat transfer coefficient and s are the surface area of the container) was calculated to be 5.32 mW/°C. Consequently, the photothermal conversion efficiency (η) of the PPZ NMs was 35.5%. Furthermore, power-dependent heating curves were generated for PPZ NMs across a gradient of laser intensities. To examine photothermal cycling stability, PPZ NMs underwent five repeated laser on/off cycles, with temperature recovery to ambient conditions between each irradiation phase. Subsequently, the CPPZ@R837 hydrogels incorporating distinct components were exposed to 808 nm laser illumination (0.3 W cm−2) while monitoring thermal response using IR imaging. The irradiation was terminated upon reaching steady-state temperature. Chemical O2 and ROS generation ability detection A ruthenium-based molecular probe Ru (dpp)3Cl2 was employed to track catalytic O2 evolution from H2O2 decomposition. The phosphorescence quenching mechanism occurs through O2-mediated energy transfer from photoexcited [Ru (dpp)3]2+ complexes. For measurement, the probe was introduced into H2O2 solution (200 μM) prior to drugs (PPZ NMs: 25 μg mL−1, Pt NPs: 4 μg mL−1). Fluorescence intensity was monitored at 60-s intervals using a fluorescence spectroscopy. The photosensitizing capability was evaluated through ABDA-mediated 1O2 detection. Upon light irradiation (665 nm, 0.1 W cm−2), ZnPc in the triplet excited state can transfer energy to ambient O2 to generate 1O2. This reactive species oxidizes ABDA, causing a measurable decrease in its 378 nm absorbance. In this experiment, various components (PDA NBs, Pt NPs, ZnPc, PPZ NMs) were separately mixed with ABDA in aqueous solution and irradiated with light. PZ NPs and PPZ NMs were separately mixed with ABDA in aqueous solution with H2O2 (200 μM) and irradiated with light. Monitor UV-Vis spectral changes at 30-s intervals to derive 1O2 generation kinetics. Trajectory and performance analysis of PPZ NMs The Brownian motion and catalytic propulsion of PPZ NMs (40 μg mL−1) were investigated under different H2O2 concentration (200 μM) via nanoparticle tracking analysis (NTA). The obtained motion paths were analyzed using visualization software to generate trajectory plots. Then, trajectory data were processed to determine mean squared displacement (MSD) trends and mean velocity. 3D tumor spheroid construction and PPZ NMs penetration study 3D tumor spheroids are widely used to evaluate drug penetration and distribution in solid tumors in vitro. Here, 4T1 cells were seeded at a density of 2000 cells/well in U-bottom ultra-low attachment plates. The culture medium was refreshed every other day, and mature spheroids formed after 6 days. The spheroids were then co-incubated with untreated PPZ NMs and H2O2 (100 μM) treated PPZ NMs for 48 h (PPZ NMs, 25.7 μg mL−1). ZnPc-derived fluorescence was visualized via fluorescence microscopy to assess PPZ NMs penetration and distribution. In vitro evaluation of antitumor efficacy To evaluate the anti-tumor efficacy of PPZ NMs in vitro, 4T1 cells were employed as the model system. The biocompatibility of PPZ NMs was initially assessed. Briefly, 4T1 cells were seeded into 96-well plates (5 × 103 cells/well) and cultured for 24 h. The cells were then treated with a range of concentrations (0, 5, 10, 20, 30 and 40 μg mL−1) of PPZ NMs for another 24 h. Cell viability was subsequently quantified using a CCK-8 assay. The toxicity of different drugs (PDA NBs, Pt NPs, ZnPc and PPZ NMs) was subsequently evaluated. In the phototoxicity assay, six experimental groups were established, including: (I) Control; (II) PDA NBs with 808 nm laser irradiation for 10 min; (III) ZnPc with 665 nm laser irradiation for 6 min; (IV) PPZ NMs with 808 nm laser irradiation for 10 min; (V) PPZ NMs with 665 nm laser irradiation for 6 min; and (VI) PPZ NMs subjected to sequential irradiation with 808 nm for 10 min followed by 665 nm for 6 min. In vitro detection of intracellular O2 levels Intracellular O2 generation from H2O2 decomposition catalyzed by PPZ NMs was monitored using the Ru (dpp)3Cl2 probe. 4T1 cells were plated in 24-well plates (3 × 104 cells/well) and cultured for 24 h. Then incubating with the O2 probe (3.42 μM) for 12 h. The cells were divided into five groups: (1) Control, (2) PDA NBs with H2O2, (3) Pt NPs with H2O2, (4) ZnPc with H2O2, (5) PPZ NMs with H2O2. Each treatment group was split into ± light irradiation subgroups. After a 12 h incubation with the respective drugs, the cells were gently washed twice with PBS. For the non-irradiation subgroups, PBS (300 μL) was added to each well and the cells were immediately imaged using an inverted fluorescence microscope. For the irradiation subgroups, DMEM (200 μL) was added to each well, irradiated with a 665 nm LED array for 6 min, and then incubated for another 2 h, and then switched to PBS for imaging. All treatments were applied at the following final concentrations: H2O2 (200 μM), PDA NBs (20 μg mL−1), Pt NPs (3.2 μg mL−1), ZnPc (2.5 μg mL−1), and PPZ NMs (25.7 μg mL−1). In vitro detection of intracellular ROS Intracellular ROS generation induced by PPZ NMs was measured using the fluorescent probe DCFH-DA. 4T1 cells were plated in 24-well plates (3 × 104 cells/well) and cultured for 24 h. The cells were divided into five groups: (1) Control, (2) PDA NBs (20 μg mL−1), (3) Pt (3.2 μg mL−1), (4) ZnPc (2.45 μg mL−1), (5) PPZ NMs (25.65 μg mL−1). Following a 12 h incubation with the respective compounds, and groups were irradiated with 665 nm light for 6 min and then further incubated for 2 h. Subsequently, the cells were then washed and loaded with DCFH-DA (2 μM) in serum-free medium for 30 min at 37 °C. After incubation, the cells were washed three times with PBS and imaged using an inverted fluorescence microscope. Transwell migration assay Four experimental groups were included: (1) Control, (2) PPZ NMs, (3) PZ NMs + H2O2, and (4) PPZ NMs + H2O2. 4T1 cells were seeded into the upper chamber (2 × 104 cells per insert) to form a barrier layer, while a higher density of 4T1 cells (4 × 104 cells per well) was plated in the lower chamber. After 24 h of co-culture, the medium was replaced. The upper chambers were supplied with treatment media containing PPZ NMs (40 μg mL−1) and/or H2O2 (100 μM). For groups requiring H2O2, the lower chambers were replenished with H2O2-containing medium (100 μM), whereas the remaining groups received fresh medium without additives. Cells were then exposed to 808 nm laser irradiation for 10 min and subsequently incubated for an additional 24 h. After incubation, Transwell inserts were gently removed. The cells in the lower chamber were washed three times with PBS, and cell migration was assessed and imaged using an inverted microscope. In vivo assessment of biodistribution and metabolic behavior A 4T1-luciferase tumor model was established by subcutaneous injection of cells (3.5 × 105, 100 μL PBS) into the right flank of BALB/c mice. The experiment was initiated when the tumor volume reached approximately 70 mm3. The mice were randomly assigned to three groups (n = 3): (I) Control, (II) CPPZ@R837 hydrogel, (III) CPZ hydrogel plus 808 nm laser irradiation. Treatments were administered via peritumoral injection (2.5 mg/kg, 100 μL). At designated time points post-injection (0.5, 2, 6, 12, 24, and 48 h), mice in the laser irradiation groups were subjected to 808 nm laser (0.5 W cm−2, 5 min) prior to imaging. The fluorescence signals at the tumor site were subsequently monitored using a vivo imaging system. In vivo evaluation of tumor inhibition and systemic biosafety Tumor-bearing mice were randomly allocated into six groups (n = 4): (I) Control, (II) CPPZ hydrogel, (III) CPPZ hydrogel plus 808 nm laser irradiation, (IV) CPPZ hydrogel plus 665 nm laser irradiation, (V) CPPZ hydrogel plus 808 nm and 665 nm laser irradiation, (VI) CPPZ@R837 hydrogel plus 808 nm and 665 nm laser irradiation. Treatments were administered via peritumoral injection (100 μL) once a week, three times in total. The hydrogel contained PPZ NMs at a dose of 2.5 mg/kg and R837 at 1 mg/kg. Throughout the 21-day treatment regimen, irradiation was performed daily: initial 808 nm irradiation (0.5 W cm−2, 2 min) targeted the hydrogel depot, followed 2 h later by simultaneous dual-wavelength irradiation (808 nm, 0.5 W cm−2, 4 min; 665 nm, 0.35 W cm−2, 3 min) at the tumor site. Body weights and tumor volumes (V = width [2]×length/2) were monitored every other day. On day 21, blood was collected via retro-orbital bleeding. The serum was separated by centrifugation for biochemical analysis. Following euthanasia by cervical dislocation, major organs and tumors were excised. Histological analysis included H&E staining of organs, and TUNEL apoptosis assay coupled with HIF-1α immunofluorescence staining on tumor sections. To evaluate systemic antitumor immunity, a bilateral 4T1 tumor model was established. Mice were randomized into three groups (n = 4): (I) Control, (II) CPPZ hydrogel plus 808 nm and 665 nm laser irradiation, (III) CPPZ@R837 hydrogel plus 808 nm and 665 nm laser irradiation. Treatments (peritumoral injection and laser irradiation) were administered only to the primary tumor on one flank, following the same protocol described in the tumor inhibition study, while the distant tumor was left untreated. The 21-day treatment course was maintained, with monitoring of body weight and tumor volumes every other day. On day 21, the mice were killed by cervical dislocation. Lung, spleen and bilateral tumors were harvested. The lung was fixed in Bouin's solution for metastatic nodule enumeration. Tumors were weighed. Single-cell suspensions from spleen and tumors were prepared for immunophenotyping by flow cytometry. Briefly, cells were Fc-blocked and subsequently stained with antibody panels. Splenocytes and tumor digests were analyzed for CD8+ T cell populations. Statistical analysis All quantitative data are reported as the mean ± standard deviation (SD). Intergroup comparisons were conducted using one-way analysis of variance (ANOVA), followed by appropriate post hoc multiple comparison tests where applicable. Statistical significance was defined as p < 0.05. Results and discussion Preparation and characterization of the CPPZ@R837 hydrogel The polymerization mechanism of PDA is a complex, multi-step chemical process, fundamentally governed by the structural transformation and self-assembly of DA molecules under oxidative conditions [25,26]. This process is typically initiated under alkaline environments or in the presence of oxidizing agents [27]. The catechol moiety within the DA molecule is oxidized to form highly reactive o-quinone intermediates. Subsequently, intramolecular Michael-type addition reactions occur, wherein the quinone group reacts with the primary amine of the dopamine itself, leading to cyclization and the formation of 5,6-dihydroxyindole or its oxidized derivatives. These intermediates undergo further oxidation and polymerize via radical coupling or π-π stacking interactions to form oligomeric chains, which eventually crosslink through C-C and C-N bonds to yield the final polymeric structure. Throughout this process, non-covalent interactions-including π-π stacking, hydrogen bonding, and charge-transfer interactions-play a pivotal role in dictating the morphology of PDA [28]. PDA exhibits robust interfacial polymerization characteristics during its formation, encompassing gas-liquid interfaces (between gas templates and water), liquid-liquid interfaces (between organic emulsion droplets and water), and solid-liquid interfaces (between solid templates and water). The bowl-shaped Janus-type PDA was fabricated using O2 nanobubble templates. The oxidative action of O2 induced the polymerization of DA molecules at the gas-liquid interface. As show in Fig. 1A, as the degree of polymerization increased, the growing internal pressure caused the nanobubble to rupture, leading to the formation of PDA NBs. The PDA NBs exhibited an average diameter of 202.7 ± 9.3 nm (Fig. S1). Subsequently, Pt, which catalyzes the decomposition of H2O2 to generate O2, was selected as the driving source. To facilitate assembly, the Pt was fabricated into ultrasmall NPs with an average size of 9.0 ± 0.8 nm (Fig. 1B and S2). The ICP analysis demonstrated that the Pt NPs loading efficiency in PDA NBs reached 0.16 mg mg−1 (Table S1). The abundant catechol/quinone and amino groups on the PDA NBs surface served as electron donors, capable of forming stable coordination bonds with the vacant d-orbitals of Pt, thereby enabling efficient loading of Pt NPs. ZnPc and PDA NBs associated through multiple interaction mechanisms. The extended π-conjugated system of ZnPc participated in π-π stacking interactions with the aromatic rings of PDA NBs. Hydrogen bonding networks formed between the carboxylate oxygen atoms and the phenolic hydroxyl groups of PDA NBs, collectively maintaining the stability of the composite. After loading ZnPc and Pt NPs via PDA NBs, the bowl-like structure was well preserved (Fig. S3). Ultraviolet characterization of the PPZ NMs revealed distinct absorption peaks characteristic of ZnPc, with a ZnPc loading capacity of 0.125 mg mg−1 (Fig. 1C and S4).Fig. 1TEM images of (A) PDA NBs, (B) Pt NPs and (C) PPZ NMs. (D) Photograph of inverted CTS hydrogels, CPPZ hydrogel and CPPZ@R837 hydrogel. (E) SEM images of CTS hydrogels, CPPZ hydrogel and CPPZ@R837 hydrogel. (F) Photograph of the CPPZ@R837 hydrogel injection process. Stress response of CPPZ@R837 hydrogel under increasing (G) strain and (H) temperature. (I) Inversion behavioral assay of CTS and CPPZ@R837 hydrogel at 50 °C. (J) The molecular mechanism underlying the thermo-responsive behavior of CPPZ@R837 hydrogel. TEM images of (A) PDA NBs, (B) Pt NPs and (C) PPZ NMs. (D) Photograph of inverted CTS hydrogels, CPPZ hydrogel and CPPZ@R837 hydrogel. (E) SEM images of CTS hydrogels, CPPZ hydrogel and CPPZ@R837 hydrogel. (F) Photograph of the CPPZ@R837 hydrogel injection process. Stress response of CPPZ@R837 hydrogel under increasing (G) strain and (H) temperature. (I) Inversion behavioral assay of CTS and CPPZ@R837 hydrogel at 50 °C. (J) The molecular mechanism underlying the thermo-responsive behavior of CPPZ@R837 hydrogel. Under acidic conditions, the amino groups of CTS become protonated, rendering the polymer soluble in water and resulting in a positively charged polymeric solution. Through appropriate crosslinking strategies, CTS molecules can form a stable three-dimensional network structure capable of entrapping a substantial amount of water, ultimately leading to the formation of a hydrogel. During the polymerization process of CTS, the incorporation of PPZ NMs and R837 did not compromise the integrity of the CTS network, the hydrogel maintained its well-defined three-dimensional structure (Fig. 1D and E). Data from EDS elemental mapping analysis of the CPPZ@R837 hydrogel (C, N, O, Zn, and Pt) revealed that Zn from ZnPc and Pt from Pt NPs were homogeneously crosslinked within the hydrogel matrix. The contents of C, N, O, Zn, and Pt were 46.38%, 8.78%, 36.10%, 2.50%, and 6.24%, respectively (Fig. S5). The injectability of the CPPZ@R837 hydrogel was significantly enhanced compared to that of pure CTS hydrogel (Fig. 1F). Changes in pressure altered the swelling equilibrium and network porosity of hydrogels, while variations in temperature significantly affected their thermodynamic state and molecular mobility [29]. Under compressive conditions, hydrostatic pressure hindered the penetration of solvent molecules into the polymer network, which effectively increased the crosslinking density and resulted in a nonlinear increase in strain force. For thermo-responsive hydrogels, when the temperature rose above the lower critical solution temperature, enhanced hydrophobic interactions among polymer chains led to network contraction and an increase in crosslinking point density, thereby causing a marked elevation in strain force. In hydrogels with a high critical temperature, elevated temperatures disrupted hydrogen bonding, promoted network swelling, and consequently reduced strain force (Fig. 1G and H). Subsequently, a resting experiment was conducted on the hydrogels. The CPPZ@R837 hydrogel exhibited a significant increase in fluidity at 50 °C, whereas the chitosan hydrogel alone remained unchanged (Fig. 1I). The -C=O groups in PDA reacted with the -NH2 groups of CTS to generate -C=N linkages, while the β-OH groups subsequently attacked the carbonyl carbon, resulting in the formation of a five-membered heterocyclic structure. Upon thermal treatment, water molecules further attacked the electron-deficient carbon center, thereby inducing ring-opening (Fig. 1J). Analysis of photothermal conversion efficiency and ROS generation capacity The efficient photothermal conversion capability of PDA primarily originates from its unique molecular structure and physicochemical properties. Structurally, PDA is formed via the oxidative self-polymerization of DA monomers, resulting in a polymer matrix rich in conjugated aromatic rings and abundant oxygen- and nitrogen-containing functional groups [30]. This distinctive conjugated system endows PDA with broad-spectrum light absorption spanning the ultraviolet, visible, and near-infrared regions, enabling it to efficiently capture photons across a wide wavelength range [31]. Upon light absorption, electrons in the PDA molecules are excited to higher energy states; however, due to the amorphous nature of PDA and its complex intermolecular interactions, the relaxation of these excited states predominantly occurs through non-radiative pathways, whereby the absorbed energy is dissipated as heat rather than through radiative transitions. Additionally, PDA exhibits remarkable photothermal stability, including resistance to photobleaching, which allows it to maintain consistent performance under prolonged light exposure. These attributes collectively highlight the significant potential of PDA in biomedical and energy-related applications. To elucidate the photothermal conversion performance of drugs, we independently investigated the photothermal responsiveness of its constituent components. As shown in Fig. 2A and B, under identical laser irradiation intensity, the temperature of PDA NBs and PPZ NMs solution increased to 67.9 ± 1.9 °C and 70.0 ± 2.5 °C, respectively, while no significant temperature rise was observed in other experimental groups. The result demonstrated that the photothermal conversion efficiency of PPZ NMs was predominantly attributed to the incorporation of PDA NBs. Furthermore, PPZ NMs exhibited a concentration-dependent photothermal response, with the heating rate increasing proportionally with the drug concentration (Fig. 2C) and laser power density (Fig. 2D). The PPZ NMs revealed a photothermal conversion efficiency of 35.5%, with no observable performance degradation over five photothermal cycling tests (Fig. 2E and F). However, whether the loading of PPZ NMs into the CTS hydrogel system affects their photothermal conversion performance remains unclear. We subsequently irradiated the CPPZ@R837 hydrogel using a near-infrared laser and found that it still exhibited excellent temperature-rising capability (Fig. S6). Subsequently, near-infrared irradiation was applied at 12 h intervals, and the cumulative release amounts of R837 and ZnPc were determined at various time points. As depicted in Fig. S7, the corresponding release rates reached 64.47 ± 1.34% and 43.78 ± 1.98% at 96 h, respectively.Fig. 2(A) Photothermal images and (B) corresponding temperature changes of different drug formulations under laser irradiation (808 nm, 0.3 W cm−2). Temperature changes of PPZ NMs under laser irradiation at different (C) concentrations (μg mL−1) and (D) laser intensities (W cm−2). (E) Photothermal conversion performance of PPZ NMs under laser irradiation, and cooling time analysis as a function of the negative natural logarithm of temperature during the cooling phase. (F) Five consecutive cycles of photothermal heating followed by natural cooling. (G) Fluorescence intensity of the O2-sensitive probe in 200 μM H2O2 solution under different drug treatments. (H) ABDA bleaching efficiency at 378 nm under light irradiation induced by various drugs. (I) Fluorescence intensity of DCFH-DA after treatment with different drugs. (A) Photothermal images and (B) corresponding temperature changes of different drug formulations under laser irradiation (808 nm, 0.3 W cm−2). Temperature changes of PPZ NMs under laser irradiation at different (C) concentrations (μg mL−1) and (D) laser intensities (W cm−2). (E) Photothermal conversion performance of PPZ NMs under laser irradiation, and cooling time analysis as a function of the negative natural logarithm of temperature during the cooling phase. (F) Five consecutive cycles of photothermal heating followed by natural cooling. (G) Fluorescence intensity of the O2-sensitive probe in 200 μM H2O2 solution under different drug treatments. (H) ABDA bleaching efficiency at 378 nm under light irradiation induced by various drugs. (I) Fluorescence intensity of DCFH-DA after treatment with different drugs. ZnPc emerged as a prototypical photosensitizer, demonstrating the ability to generate cytotoxic ROS upon photoexcitation under normoxic conditions, thereby inflicting substantial oxidative damage on solid tumor [32]. Nevertheless, the intrinsically hypoxic tumor microenvironment imposed severe constraints on ROS-mediated therapeutic efficacy [33,34]. The concentration of H2O2 in the tumor microenvironment is significantly elevated compared to that in normal tissues, a phenomenon primarily attributed to aberrant tumor cell metabolism and dysregulated redox homeostasis. Under normal physiological conditions, intracellular H2O2 levels are maintained at a low concentration ranging from 0.1 to 1 μM, where it participates in various signaling pathways and regulatory processes. In contrast, within tumor tissues, H2O2 concentrations can increase to 50-100 μM [35,36]. The catalytic decomposition of H2O2 into O2 by Pt NPs is predominantly governed by their unique surface chemistry and superior electron transfer capabilities. Upon contact with the NPs surface, the d-orbitals of Pt interact with the O-O bond in H2O2 molecules, weakening and activating the bond and thus facilitating its cleavage. The H2O2 molecules are adsorbed onto the active sites of the Pt NPs, forming unstable transition states. Subsequently, the O-O bond undergoes homolytic cleavage catalyzed by the Pt, generating hydroxyl radicals. These radicals further react on the Pt surface, combining to form water and releasing O2 [37,38]. Herein, both Pt NPs and PPZ NMs exhibited efficient catalytic activity toward H2O2, leading to the generation of O2 and consequent quenching of the O2-sensitive fluorescent probe (Fig. 2G). The ROS generated by ZnPc-based photosensitizers in PDT include 1O2, superoxide anion radicals, hydroxyl radicals, and H2O2. Among these, 1O2 is the predominant and most effective ROS involved in photodynamic action. In addition, ZnPc photosensitizers can undergo electron transfer reactions with biomolecules or solvent molecules to produce superoxide anion radicals. These radicals can be further converted into H2O2, which, in the presence of metal ions, can participate in Fenton-type reactions to yield highly reactive hydroxyl radicals with stronger oxidative potential. Subsequently, we assessed the ROS generation capabilities of different formulations. As shown in Fig. 2H and I, the primary source of ROS production in the PPZ NMs was zinc ZnPc. However, the ROS generation efficiency of the PPZ NMs was slightly lower than that of free ZnPc. This reduction was likely due to insufficient light absorption and the reductive properties of PDA NBs. To further verify the crucial role of Pt NPs in the generation of ROS, we comparatively analyzed Pt-free PZ NPs and Pt-containing PPZ NMs in an aqueous H2O2 solution under light irradiation. The experimental results showed that the photobleaching of ABDA in the PPZ NMs group was more pronounced, indicating that ZnPc exhibits superior 1O2 generation ability in the presence of Pt (Fig. S8). The propulsion behavior analysis of CPPZ@R837 hydrogel The above experiments confirmed that PPZ NMs showed good O2-generating capability. In addition to alleviating tumor hypoxia, the generated gas also served as an important driving force for PPZ NMs propulsion. We simulated the tumor microenvironment with elevated H2O2 levels in both aqueous solution and cellular contexts to study the motility behavior of the PPZ NMs. The Brownian motion of NPs is fundamentally a statistical manifestation of molecular thermal motion, quantitatively described by the Einstein equation. This phenomenon not only underpins the stable existence of NPs in liquid phases but also provides a natural diffusion-driven force for applications such as drug delivery and environmental remediation [39,40]. In particular, in the biomedical field, the efficiency of NPs-based drug delivery largely depends on the diffusion facilitated by Brownian motion. The motion trajectories of PZ NPs exhibited characteristic Brownian motion regardless of the presence or absence of H2O2 (Fig. 3A and B). However, in the case of PPZ NMs, the motion range in H2O2-free aqueous solution was relatively limited, whereas a significant increase in motion range was observed in the presence of H2O2 (Fig. 3C and D). These results indicated that Pt NPs serves as the driving force for the motion of the PPZ NMs. Subsequently, we performed a quantitative analysis of the motility of PPZ NMs, including measurements of mean square displacement (MSD), diffusion coefficient (De), and velocity (v). Compared with other experimental groups, the MSD-Δt curve of PPZ NMs in H2O2 solution showed a rapid linear increase (Fig. 3E). According to the equation De = MSD/(4×Δt), the effective diffusion coefficient of PPZ NMs increased from 1.4 to 8.9 in H2O2 solution relative to that in pure water (Fig. 3F), with a maximum velocity reaching 19.2 μm s−1 (Fig. 3G).Fig. 3Trajectory plots of individual PZ NPs or PPZ NMs in aqueous solutions with and without H2O2 (A: PZ NPs without H2O2, B: PZ NPs with H2O2, C: PPZ NMs without H2O2, D: PPZ NMs with H2O2). (E) MSD as a function of the time interval (Δt), obtained from particle tracking trajectories. (F) Diffusion coefficient (Dt) calculated from the linear fitting of the MSD curves. (G) Comparison of the average motility speeds between PZ NPs and PPZ NMs. (H) Fluorescence analysis of nanomedicine migration and penetration across transwell chambers (bar = 100 μm). (I) Fluorescence imaging of PZ Ns and PPZ NMs penetration within 3D tumor spheroids. Trajectory plots of individual PZ NPs or PPZ NMs in aqueous solutions with and without H2O2 (A: PZ NPs without H2O2, B: PZ NPs with H2O2, C: PPZ NMs without H2O2, D: PPZ NMs with H2O2). (E) MSD as a function of the time interval (Δt), obtained from particle tracking trajectories. (F) Diffusion coefficient (Dt) calculated from the linear fitting of the MSD curves. (G) Comparison of the average motility speeds between PZ NPs and PPZ NMs. (H) Fluorescence analysis of nanomedicine migration and penetration across transwell chambers (bar = 100 μm). (I) Fluorescence imaging of PZ Ns and PPZ NMs penetration within 3D tumor spheroids. Due to the highly adhesive nature of the hydrogel, whether the PPZ NMs were able to effectively propel and diffuse within the nanomotor-loaded hydrogel matrix was of critical importance. The transwell chamber is a widely adopted in vitro model for simulating biological barriers and evaluating drug delivery systems [40]. Its fundamental principle involves the separation of upper and lower compartments by a porous membrane, allowing the study of transmembrane transport behaviors of drugs or carriers [41]. During the experiment, the drug-loaded hydrogel is placed in the upper chamber, while the lower chamber collects the permeated drug. The drug is initially released from the hydrogel matrix and subsequently diffuses through the microporous membrane under the influence of a concentration gradient, ultimately reaching the lower compartment. By quantifying the drug concentration in the lower chamber at predetermined time points, parameters such as cumulative release, permeation rate, and apparent permeability coefficient can be determined, thereby enabling a comprehensive evaluation of the hydrogel's sustained-release behavior and delivery performance. To monitor the transmembrane penetration of CPPZ@R837 hydrogel within the chamber, a commercial fluorescent probe (Cy3-NHS) was conjugated to the surface of the PPZ NMs. 4T1 cells were seeded in the upper chamber of a transwell insert to mimic the tumor tissue barrier, while twice the number of 4T1 cells were seeded in the lower chamber. The system was incubated in a cell culture incubator for 24 h. After removing the culture medium, fresh medium or different types of hydrogels were added to the upper chamber. Following laser irradiation, the CPPZ@R837 hydrogel group exhibited the strongest fluorescence signal, indicating the highest drug penetration capacity (Fig. 3H and S9). The 3D tumor spheroid is one of the representative models for evaluating drug penetration capability. In this study, 4T1 and HFL-1 tumor spheroids were employed to assess the deep tissue penetration ability of the CPPZ@R837 hydrogel in solid tumor models. The CPPZ@R837 hydrogel, with or without H2O2 pretreatment, was co-incubated with the 3D cell spheroids, and intracellular fluorescence of PPZ NMs was examined using laser confocal microscopy. The CPPZ@R837 hydrogel subjected to laser irradiation exhibited red fluorescence only at the periphery of the spheroids, with no detectable fluorescence in the core region, indicating that PPZ NMs did not penetrate into the spheroid center. In contrast, in the group pretreated with H2O2 and subsequently irradiated, distinct red fluorescence was observed both at the periphery and within the core of the spheroids, demonstrating that the drug successfully penetrated into the spheroid center. These results indicated that H2O2 pretreatment enhanced the motility of the CPPZ@R837 hydrogel, thereby significantly improving its tumor tissue penetration capability and enhancing its antitumor efficacy (Fig. 3I). In vitro antitumor activity of CPPZ@R837 hydrogel To determine the appropriate administration dose, the dark cytotoxicity of PPZ NMs at different concentrations was evaluated. When the concentration was below 20 μg mL−1, the cell viability remained above 90% (Fig. 4A). This concentration was selected as the reference dose for subsequent drug treatments. Co-incubation with cells at this dosage did not induce appreciable cytotoxic effects, confirming that it lies within the safe therapeutic window (Fig. 4B). Subsequently, the extent of cellular damage in different treatment groups was evaluated following various light irradiation conditions, and the experimental results are presented in Fig. 4C. As shown, the photothermal effect of PDA NBs and the photodynamic activity of the ZnPc induced significant cytotoxicity, with cell viabilities of 86.2 ± 7.4% and 76.9 ± 5.2%, respectively. The PPZ NMs produced photothermal damage comparable to that of PDA NBs. However, under 665 nm irradiation, they demonstrated significantly enhanced photodynamic antitumor activity relative to the ZnPc alone. This enhanced efficacy can be attributed to the intrinsic requirement of O2 for PDT and the unique ability of the PPZ NMs to catalyze H2O2 decomposition, thereby generating O2 and alleviating tumor hypoxia. The cell viability in the PPZ NMs-mediated PTT group was 80.6%, whereas that in the PDT group was 58.5%. In contrast, the combined PPZ NMs-based PTT/PDT treatment markedly reduced tumor cell viability to 23.7%, with a synergistic index of 1.65, indicating a significant synergistic antitumor effect. Furthermore, cell viability was assessed using a Calcein-AM/PI double-staining assay, and the fluorescence results were consistent with the CCK-8 assay findings (Fig. 4D). Alleviating tumor hypoxia was critical for enhancing the antitumor efficacy of photosensitizers. We employed a probe to detect O2 levels under both light and dark conditions in different treatment groups. As shown in Fig. 4E, under dark conditions, the fluorescence intensity in the Pt NPs-treated and PPZ NMs-treated groups was markedly reduced, which was attributed to fluorescence quenching caused by elevated oxygen levels. In contrast, upon light irradiation, the fluorescence intensity of the PPZ NMs-treated group was enhanced, resulting from O2 consumption during the photodynamic process. O2 serves as the reactive substrate for ZnPc to generate ROS, and the elevated O2 concentration markedly enhanced the ROS-producing capacity of the PPZ NMs (Fig. 4F).Fig. 4(A) Concentration-dependent toxicity of PPZ NMs. (B) Dark toxicity and (C) phototoxicity of various formulations toward 4T1 cells. (D) Cell viability evaluation via live/dead staining across different treatment groups. (E) Comparative analysis of intracellular O2 levels with (+) and without (−) light irradiation. (F) Representative fluorescence images and corresponding quantitative analysis of ROS levels. (A) Concentration-dependent toxicity of PPZ NMs. (B) Dark toxicity and (C) phototoxicity of various formulations toward 4T1 cells. (D) Cell viability evaluation via live/dead staining across different treatment groups. (E) Comparative analysis of intracellular O2 levels with (+) and without (−) light irradiation. (F) Representative fluorescence images and corresponding quantitative analysis of ROS levels. In vivo metabolic distribution of CPPZ@R837 hydrogel To evaluate the intratumoral penetration capability of CPPZ@R837 hydrogel following peritumoral injection, the IVIS imaging system was employed for real-time monitoring. This experiment was designed to dynamically observe, in a non-invasive manner, the spatial distribution and temporal evolution of the drug carrier within the tumor microenvironment, and to qualitatively and quantitatively assess its penetration performance. For precise tracking, the PPZ NMs were pre-labeled with the Cy3-NHS probe, which possesses strong tissue penetration ability and low background autofluorescence, thereby significantly improving the signal-to-noise ratio and tracking accuracy in vivo. BALB/c mice bearing established subcutaneous tumors were randomly divided into three groups (n = 3): the control group, CPPZ@R837 hydrogel treatment group, and CPPZ@R837 hydrogel plus laser irradiation group. Immediately after drug administration, the tumor-bearing mice were placed into the IVIS imaging chamber, and real-time fluorescence images were acquired under identical exposure parameters and filter settings. To comprehensively capture the diffusion process of the drug within the tumor tissue, imaging was performed at multiple predetermined time points (0.5, 2, 6, 12, 24 and 48 h), with a focus on monitoring changes in fluorescence intensity and spatial distribution within the tumor region. The acquired images were analyzed using the dedicated software of the imaging system. The tumor area was delineated as the region of interest (ROI), and the mean fluorescence intensity (MFI) within the ROI was calculated. The results showed that, following peritumoral injection, CPPZ@R837 hydrogel in the laser irradiation group gradually and uniformly spread from the injection site toward the central tumor region. Over time, the fluorescence signal extended deeper into the tumor tissue, indicating penetration into poorly perfused and hypoxic areas (Fig. 5 and S10). Further quantitative analysis demonstrated that the hydrogel system integrated with active propulsion components not only achieved sustained local drug release but also overcame the passive diffusion limitations imposed by the dense tumor stroma, thereby enhancing intratumoral drug distribution. This enhancement may be attributed not only to the physical propulsion effect of the nanomotors but also to local modulation of the tumor microenvironment, both of which synergistically facilitated drug migration within the interstitial matrix.Fig. 5Fluorescence distribution of the CPPZ@R837 hydrogel in subcutaneous tissues at different time points following peritumoral administration in mice. Fluorescence distribution of the CPPZ@R837 hydrogel in subcutaneous tissues at different time points following peritumoral administration in mice. To further quantify the tumor-penetrating effect of the CPPZ@R837 hydrogel, a mouse subcutaneous tumor model was established. The mice were randomly allocated into five groups (n = 4): Group I (control), Group II (CPPZ@R837 hydrogel), Group III (CPPZ@R837 hydrogel combined with 808 nm laser irradiation), Group IV (CPZ@R837 hydrogel plus 808 nm laser irradiation), and Group V (CPPZ@R837 hydrogel with 808 nm laser irradiation). Of particular note, PDA was employed in the form of nanospheres in Group III, whereas nanobowls were used in all other treatment groups. The phthalocyanine ring possesses a highly conjugated, rigid planar aromatic macrocyclic structure with highly delocalized π electrons, which effectively reduces non-radiative transition losses of excited molecules and thereby endows it with a high fluorescence quantum yield. Based on this property, tumor tissues harvested from mice after various therapeutic regimens were sectioned and subjected to fluorescence imaging analysis. As shown in Fig. S11A, the fluorescence intensity in the tumor tissues of the bowl-shaped nanomotor hydrogel group was significantly stronger than that of the spherical nanomotor hydrogel group, while the fluorescence signal in the hydrogel group without Pt NPs was remarkably decreased. Meanwhile, inductively coupled plasma (ICP) spectrometry was employed to quantitatively determine the contents of Zn and Pt in tumor tissues. The results demonstrated that there was no significant difference in Zn content among different groups, which might be attributed to the relatively high intrinsic Zn level in tumor tissues. In contrast, the Pt content in the Pt-loaded bowl-shaped nanomotor hydrogel group was notably higher than those in the Pt-free bowl-shaped hydrogel group and the spherical nanomotor hydrogel group (Fig. S11B and 11C). Collectively, the above results convincingly verify that the nanomotor hydrogel constructed in this study enables efficient penetration into tumor tissues. In vivo antitumor activity evaluation of CPPZ@R837 hydrogel The in vivo antitumor efficacy of the CPPZ@R837 hydrogel was evaluated using 4T1 tumor-bearing mice, in which peritumoral injection combined with light irradiation was administered as the treatment strategy. A schematic illustration of the treatment procedure was shown in Fig. 6A. Tumor growth was rapid in both the control and hydrogel-only groups, whereas peritumoral hydrogel injection with 808 nm laser irradiation partially inhibited tumor progression via photothermal decomposition and subsequent PPZ NM release. Under neutral conditions, particularly in the presence of sufficient O2, Pt NPs functioned analogously to “catalase,” catalyzing the decomposition of H2O2 into O2 and water, thereby enhancing the motility of PPZ NMs. In contrast, under acidic conditions, Pt NPs behaved more like “peroxidase,” catalyzing the decomposition of H2O2 into hydroxyl radicals and other ROS, which oxidatively damaged tumor tissues [42,43]. Notably, irradiation of tumor tissues with a 665 nm laser alone failed to induce significant tumor shrinkage, which was attributed to the limited penetration of PPZ NMs that primarily remained in the peritumoral region. However, when the peritumoral hydrogel was first irradiated with an 808 nm laser, followed by tumor irradiation with a 665 nm laser, the tumor growth inhibition rate reached 83.7% (Fig. 6B and C). These results indicated that photothermal effect-triggered nanomotors effectively escaped from the CTS hydrogel, achieved gas-driven deep penetration into solid tumors, and subsequently, upon 665 nm irradiation, facilitated photosensitizer-mediated generation of abundant ROS in the presence of O2, thereby eliciting potent tumor cell ablation. To suppress tumor metastasis and recurrence, the immunoadjuvant R837 was incorporated into the hydrogel (CPPZ@R837 hydrogel). R837 can activate and potentiate the host's immune response, particularly the antitumor immune response. By mimicking viral RNA components, it stimulates Toll-like receptor 7 (TLR7) on the surface of immune cells, thereby initiating a cascade of immune reactions [44]. The results demonstrated that the CPPZ@R837 hydrogel exhibited markedly enhanced antitumor efficacy, achieving even complete tumor ablation, which highlights its substantial translational potential.Fig. 6(A) Schematic illustration of the establishment of 4T1 tumor-bearing mice model and the subsequent drug treatment procedure; (B) Tumor volume changes during the treatment period, (C) quantitative comparative analysis, and (D) representative images of dissected tumor tissues. (E) H&E-stained sections, (F) TUNEL fluorescence staining, and (G) HIF-1α immunofluorescence staining of tumor tissues collected from different treatment groups after the completion of therapy. (A) Schematic illustration of the establishment of 4T1 tumor-bearing mice model and the subsequent drug treatment procedure; (B) Tumor volume changes during the treatment period, (C) quantitative comparative analysis, and (D) representative images of dissected tumor tissues. (E) H&E-stained sections, (F) TUNEL fluorescence staining, and (G) HIF-1α immunofluorescence staining of tumor tissues collected from different treatment groups after the completion of therapy. Further anatomical examinations of solid tumors directly confirmed the above findings: in the group treated with CPPZ@R837 hydrogel combined with 808 nm and 665 nm laser irradiation, tumor volume was markedly reduced, with a loosened texture and evident necrotic lesions, whereas tumors in the control group remained compact with abundant blood supply (Fig. 6D). Histopathological analysis of tumor tissues was conducted using H&E staining. Tumor cells in the control group appeared densely arranged with intact nuclei and cytoplasm, whereas the CPPZ@R837 hydrogel combined with dual-laser irradiation induced extensive necrosis and pronounced structural disruption (Fig. 6E). TUNEL staining further indicated that this treatment induced massive apoptosis, confirming its pronounced pro-apoptotic activity (Fig. 6F). It is noteworthy that tumor hypoxia is a critical factor limiting PDT [45,46]. HIF-1α staining confirmed high basal expression levels in tumors, which were further elevated in the CPPZ@R837 hydrogel plus 665 nm laser group due to O2 consumption. In contrast, all groups treated with 808 nm laser irradiation showed reduced HIF-1α expression, likely resulting from Pt NP-mediated catalytic decomposition of H2O2 into O2, thereby alleviating hypoxia (Fig. 6G). In vivo biosafety evaluation of CPPZ@R837 hydrogel During the treatment period, the body weight of the mice was continuously monitored, and no body weight loss was observed (Fig. S12). After the treatment, histopathological examinations of major organs and serum biochemical analyses were performed. Cardiac tissue sections revealed regularly arranged myocardial fibers with distinct striations and normal nuclear morphology of cardiomyocytes, without evidence of fiber rupture, necrosis, or inflammatory infiltration. Hepatic histology showed an intact lobular architecture, hepatocytes with abundant cytoplasm, and distinct nucleoli. In the spleen, a clear boundary between white pulp and red pulp was observed, with no signs of extramedullary hematopoiesis or fibrotic lesions. Pulmonary tissues preserved intact alveolar structures with uniformly distributed capillary networks within the alveolar septa. Renal histological evaluation demonstrated clear glomerular capillary loop structures, no narrowing of Bowman's capsule space, intact brush borders of proximal tubules, and orderly morphology of distal tubular epithelial cells (Fig. 7A).Fig. 7(A) H&E staining of major organs in mice after treatment with different drugs (bar = 100 μm). Analysis of hematological parameters in mice after completion of treatment (B: ALT, C: AST, D: T-BIL, E: CREA, F: BUN, and G: UA). (A) H&E staining of major organs in mice after treatment with different drugs (bar = 100 μm). Analysis of hematological parameters in mice after completion of treatment (B: ALT, C: AST, D: T-BIL, E: CREA, F: BUN, and G: UA). Following peritumoral subcutaneous administration, the drug is not completely confined to the local tissue but may enter the systemic circulation through multiple pathways. First, the subcutaneous tissue is richly supplied with capillaries, allowing the released drug to directly diffuse into the bloodstream. Once in circulation, it can be distributed to the liver and kidneys, where the liver, as the primary metabolic organ, mediates biotransformation of the drug and its metabolites, while the kidneys eliminate them via filtration and secretion. Second, macromolecular formulations or nanoparticles can be absorbed through lymphatic capillaries and subsequently returned to the bloodstream via lymphatic drainage, ultimately reaching the liver and kidneys as well. In addition, local administration may induce inflammatory responses or tissue necrosis, and the release of inflammatory mediators into circulation could indirectly impair distal organ functions. Therefore, even when employing local administration, it remains essential to systematically evaluate hepatotoxicity and nephrotoxicity in mice to ensure both the safety of the administration route and the reliability of experimental outcomes. Serum biochemical assays indicated that hepatic function parameters, including alanine aminotransferase and aspartate aminotransferase, remained within normal ranges, and total bilirubin showed no elevation. Renal function indicators, including creatinine and blood urea nitrogen, were maintained within physiological levels, while uric acid exhibited no abnormal increase (Fig. 7B–G). Collectively, both histological and biochemical analyses demonstrated that the CPPZ@R837 hydrogel showed excellent biocompatibility and biosafety. In vivo immune response assessment of CPPZ@R837 hydrogel To comprehensively evaluate the long-term antitumor efficacy, a bilateral 4T1 tumor-bearing model was established (Fig. 8A). The mice with bilateral tumors were assigned to the following groups: (I) Untreated Control, (II) CPPZ hydrogel treatment with 808 nm and 665 nm laser irradiation, and (III) CPPZ@R837 hydrogel treatment with 808 nm and 665 nm laser irradiation. During the treatment period, no significant body weight loss was observed in any of the mice (Fig. 8B). The growth profile of the primary tumors was consistent with the previous results. Notably, for the distant tumors, both the CPPZ hydrogel with laser irradiation and the CPPZ@R837 hydrogel with laser irradiation exhibited measurable growth suppression, while a more pronounced inhibitory effect was observed in the CPPZ@R837 hydrogel group under laser exposure. These findings indicated that the R837-induced immune activation effectively reinforced systemic antitumor immunity, thereby contributing to the suppression of metastatic tumor growth (Fig. 8C–F). One of the most salient features of the 4T1 tumor-bearing mouse model in breast cancer research is its pronounced tendency for spontaneous lung metastasis. This attribute solidifies its status as a gold-standard preclinical tool, especially for probing the mechanistic underpinnings of breast cancer dissemination to the pulmonary environment [47,48]. At the end of the treatment, the mice were euthanized via cervical dislocation, and the lungs were collected for fixation and staining. Remarkably, the number of metastatic nodules in the lungs of the CPPZ@R837 hydrogel plus laser irradiation group was substantially lower than that in the CPPZ hydrogel plus laser irradiation group, indicating enhanced suppression of lung metastasis (Fig. 8G and H). Then, CD8+ T cells isolated from distant tumors and spleen tissues were analyzed by flow cytometry to evaluate systemic immune activation. As shown in Fig. 8I and J, the CPPZ@R837 hydrogel combined with laser irradiation induced a markedly higher activation of CD8+ T cells compared with the CPPZ hydrogel plus laser irradiation group. These findings suggested that CPPZ@R837 hydrogel effectively reactivated cytotoxic T lymphocytes and enhanced the systemic antitumor immune response.Fig. 8(A) Schematic of the bilateral 4T1 tumor-bearing mouse model and treatment process. (B) Changes in body weight of tumor-bearing mice during the treatment period. Growth curves of (C) proximal and (D) distal tumors in tumor-bearing mice during the treatment period. Comparison of (E) proximal and (F) distal tumor weights in tumor-bearing mice after treatment. (G) Comparative analysis of mice lung tissues and (H) the number of pulmonary nodules stained with Bouin's solution. CD8+ T cells in (I) distant tumors and (J) spleen tissues. (A) Schematic of the bilateral 4T1 tumor-bearing mouse model and treatment process. (B) Changes in body weight of tumor-bearing mice during the treatment period. Growth curves of (C) proximal and (D) distal tumors in tumor-bearing mice during the treatment period. Comparison of (E) proximal and (F) distal tumor weights in tumor-bearing mice after treatment. (G) Comparative analysis of mice lung tissues and (H) the number of pulmonary nodules stained with Bouin's solution. CD8+ T cells in (I) distant tumors and (J) spleen tissues. Conclusion In the treatment of solid tumors, the highly compact extracellular matrix and complex tumor microenvironment severely restrict the penetration efficiency of nanomedicines. This limitation is particularly pronounced in peritumoral injectable hydrogel delivery systems, where insufficient drug diffusion has become a critical bottleneck for further therapeutic improvement. In this study, we demonstrated that the self-propelled motion of NMs, driven by external propellants, markedly enhanced the intratumoral migration and spatial distribution of nanodrugs, effectively overcoming the tissue penetration barriers and thereby significantly improving the phototherapeutic efficacy against deeply located tumor cells. Moreover, the combination with an immune adjuvant not only further strengthened the eradication of primary tumors but also successfully activated systemic antitumor immune responses, leading to remarkable inhibition of distant metastasis and tumor recurrence, highlighting the potential of synergistic therapy. However, it should be noted that the current motion behavior of nanomotors remains predominantly random and non-directional, lacking active targeting and accumulation capabilities toward tumor regions. This limitation partly constrain their effective retention and the full realization of therapeutic benefits at lesion sites. Therefore, future research should focus on developing intelligent NM systems with environmental responsiveness, enabling controllable motion direction and targeted enrichment within tumor tissues to achieve more precise and efficient therapeutic outcomes under complex physiological conditions. CRediT authorship contribution statement Jiahui Jiang: Conceptualization, Data curation, Formal analysis, Writing – original draft. Yangbo Lv: Conceptualization, Data curation, Writing – original draft. Mengyuan Ma: Data curation, Formal analysis, Validation. Hanyue Xu: Data curation, Formal analysis. Mingxin Sun: Data curation, Formal analysis. Cheng Chen: Data curation, Formal analysis. Tao Cao: Data curation, Formal analysis. Yue Zhang: Conceptualization, Data curation, Writing – review & editing. Peng Cao: Conceptualization, Funding acquisition, Writing – review & editing. Qichen Zhan: Conceptualization, Data curation, Project administration, Writing – review & editing. Jianguang Xu: Data curation, Project administration, Writing – review & editing. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.